ArticleOncotarget2017

The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.

Jing-Hui Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.